Gilead Sciences Inc. - GILD (NASDAQ-GS)

80.91
1.51 (1.90%)
Quotes delayed 15 mins. Currently February 24, 2018 8:54:12 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Gilead develops and markets products in the HIV/AIDS, liver diseases, respiratory and cardiovascular therapeutic areas

Key Financials

Day Range:79.29 - 80.94
52 Week Range:63.76 - 89.54
Open:79.82
Shares:1.31B
Market Cap:105.83B
EPS:3.48
P/E Ratio:23.30
Div Yield:2.82
Performance
Previous close
No Chart Available
Purchase GILD in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of GILD not only as a single stock, but also as part of a motif.
Professional Motifs with GILD
Biotech Breakthroughs
Biotech Breakthroughs 6.0% 1 YR RTN Biotech firms are breathing new life into hope for cures for complex diseases like cancer, arthritis and AIDS.
View all professional motifs with GILD
Community Motifs with GILD
Innovation Ahead
Innovation Ahead 16.6% 1 YR RTN
HitBig
HitBig -- 1 YR RTN
JNJ Winners
JNJ Winners 24.0% 1 YR RTN
View all community motifs with GILD
What Others Think About GILD
John Carroll
Top 5 for the week: #1 - the gene editing surprise --
All in: Gilead maps a $3.15B gene editing alliance with Sanga… twitter.com/i/web/status/9…
9 17
Ophir Gottlieb
In focus: $AAPL $GOOGL $NVDA $MSFT $GILD $DIS

Join us.

"A volatile market can be a once in a generation opportuni… twitter.com/i/web/status/9…
8 2
John Carroll
All in: Gilead maps a $3.15B gene editing alliance with Sangamo for off-the-shelf CAR-T drugs
$GILD $CELG $NVS
endpts.com/all-in-gilead-…
24 50
BioPharma Dive
#ICYMI The antiretrovirals $GILD developed on the sofosbuvir backbone have earned the company roughly $55B since 20… twitter.com/i/web/status/9…
MattBurns
RT @EGolgher : Weekly Stock Market Review: Top Tech Stock Picks For This Week
messages.responder.co.il/3035955
$AAPL $AMD $NVDA $TSLA $WMT $FB $MSF…
2
Mike Robinson
RT @Biotech2050 : $SGMO bull case on just $GILD Deal:
Number of indications: 10 (probably more)
Avg revenue per indication $800M - $2B+ (tak…
2
Jordan Alexander
@RNAiAnalyst YOU should be ridiculed, not $GILD $SMGO deal! You were dead wrong from $3, just let it go and stay low!
1
Brian Firestone
Where Are The CNBC Tweets on #Allergan 's Latest Patent News? Anybody? $aapl $tst $myl $mrk $vrx $iep $ibm $prgotwitter.com/i/web/status/9…
Related Companies Within The Biotechnology Sector
TIG
TiGenix - 40.77
TIG
Amgen Inc. - 186.67
AMGN
CELG
Biogen Inc. - 292.78
BIIB